US stock trading

May 10, 2024

<Research>CLSA Forecasts Baidu (BIDU.US) 1Q24 Core Rev. Growth to Slow to 3%, w/ 3% Drop in Adj. EBIT

CLSA forecasted in a report that BIDU-SW (09888.HK)  -0.200 (-0.186%)    Short selling $82.99M; Ratio 11.602%   (BIDU.US)      would report slower core revenue growth of 3% YoY to RMB23.7 billion in 1Q24, while adjusted EBIT is forecast to fall 3% YoY to RMB5.2 billion, mainly due to the weakening macroeconomy. Demand for advertising in the healthcare, travel and e-commerce sectors remained strong, while demand for advertising in the property, automotive and franchising sectors was weak.

Read More
May 8, 2024

AstraZeneca (AZN.US) Ceases Sale of Covid Vaccine Globally

AstraZeneca (AZN.US)      said it has begun to stop selling its Covid vaccine Vaxzevria globally and will retract the marketing authorisation for the vaccine in Europe, as a result of the development of several vaccines against mutated Covid viruses and a surplus of available boosters, which has led to a decline in demand for Vaxzevria.

Read More